Full-Time
Cultivation Technician
Jushi
201-500 employees
Cannabis products brand and wellness solutions
No salary listed
Sparks, NV, USA
In Person
Bachelor's
 Lab & Research (1) |
|---|
Get referred to Jushi
See people who can refer or advise you
- Degree in Horticulture, Plant Science, Agronomy, Plant Biology, or related field
- minimum of 2 years of experience cultivating plants
- registered in the Commonwealth of Virginia as a Pharmacy Technician
- Must pass background and drug screening
- Knowledge of large-scale commercial plant cultivation, including but not limited to nutrient requirements, growing media, light requirements, temperature control, and airflow
- Experience with compliance systems
- Advanced cannabis plant and genetics knowledge
- Must accept accountability, have a proactive attitude, and demonstrate consistent attention to detail
- Active listening and effective verbal and written communication skills, including the ability to effectively communicate to a variety of audiences
- Basic math skills
- Basic understanding of applicable federal, state, and local laws and regulations, and particularly those governing cannabis, and organizational rules, directives, and Standard Operating Procedures
- Ability to work independently throughout the day in accordance with instructions
- Ability to use standard office equipment, and particularly computer equipment and software such as word processing, database management, spreadsheet applications, and electronic mail
- Ability to work effectively with other employees, management, customers, government representatives such as facility inspectors
- Responsible to complete any work assigned during scheduled shifts
- Provide any necessary support to the management team to ensure cultivation duties are efficiently and timely completed in a manner consistent with the company’s Standard Operation Procedure for each duty
- Initial Cultivation Associate duties will involve essential Cultivation operations and may be expanded over time
- Daily responsibilities include: plant work, and specifically (but not exclusively) big leaf and bottom stripping in flower rooms, seed-to-sale tracking data input, sweeping and disinfecting flower/vegetative rooms, disposing of used growing media, preparing rooms for a refill, and all general cleaning
- Weekly responsibilities include: spot cleaning, flipping flower blocks, consolidating vegetative trays, planting coco cubes, watering, and light maintenance
- Monthly responsibilities include: harvesting and big leafing, applying predatory insects, hanging sticky cards for IPM monitoring, helping with monthly on-hand inventory counts, assisting with safety meetings, taking clones, and rotating mother plants
- Responsible to follow all applicable operational guidelines, comply with verbal directives, and practice and/or implement all safety, security, sanitation, policies, procedures, rules, skills, and the like presented during training, by management, in Standard Operating Procedures, or otherwise when performing job duties
- Responsible to understand and follow all GACP/GMP guidelines throughout the facility
- Perform such other duties as employee is qualified to perform and may be assigned
Jushi Holdings is a cannabis company aiming to be a world-class leader by building an integrated global community focused on wellness, mindfulness, and connection. It develops and sells cannabis products with strong branding and trusted quality across growing markets. Its products come from cultivation and manufacturing processes, then are branded and distributed to consumers to support wellness and everyday use. The company differentiates itself through its emphasis on branding, quality, and an integrated platform that links cultivation, product development, and distribution across multiple regions. Its goal is to become a leading global cannabis brand and platform that connects people seeking wellness through cannabis products.
Company Size
201-500
Company Stage
IPO
Headquarters
Boca Raton, Florida
Founded
2018
Get referred to Jushi
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue grew 9.6% and wholesale jumped 68%, signaling improving demand.
- Q2 2026 cash from operations reached $0.8 million, while six-month operating cash flow hit $9.4 million.
- Federal Schedule III rescheduling should reduce Section 280E tax burden across Jushi’s medical-heavy footprint.
What critics are saying
- Jushi carries $219.8 million debt at 12.5% due March 2029, crushing free cash flow.
- The Virginia lawsuit against DoorDash and Total Wine risks expensive defeat and distraction through 2027.
- Ongoing pricing pressure cut Q2 2026 EBITDA margin to 18.7%, exposing Jushi to commoditization.
What makes Jushi unique
- Jushi’s July 28, 2026 revenue hit $71.3 million across 42 stores and wholesale.
- Virginia and Ohio give Jushi regulated-state density, especially where adult-use or hemp fights matter.
- CEO James Cacioppo and Denis Arsenault personally financed the March 27, 2026 refinancing.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Short-and Long-Term Disability
Flexible Spending Accounts
Paid Time Off
Paid Holidays
401(k) Retirement Plan
401(k) Company Match
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↓ -1%2 year growth
↑ 0%Jushi Holdings Inc reported Q2 2026 revenue of $71.3 million, up 9.6% from $65 million in the prior year quarter. Wholesale revenue surged 68% year-over-year to a record $9.4 million, whilst retail revenue increased approximately 4% to $61.9 million. The company posted a net loss of $7.3 million, an improvement from the prior year's $12.3 million loss. Adjusted EBITDA came in at $13.3 million with an 18.7% margin, down from 21.1% in the prior year quarter. Federal rescheduling of state-licensed medical cannabis from Schedule I to Schedule III resulted in a one-time income tax benefit of approximately $6.4 million. The company ended the quarter operating 42 stores, compared to 40 stores a year earlier. Jushi faces ongoing pricing pressure and increased promotional activity impacting margins.
Jushi Holdings reported Q1 2026 revenue of $66.4 million, up 4% year-over-year, though pricing pressures persisted across markets. Wholesale revenue rose 22.2%, driven by growth in Massachusetts and Ohio. Gross profit increased to $29.9 million, representing 45% of revenue, compared to 40.4% in the prior year. Adjusted EBITDA reached $11.4 million, with margins improving to 17.2% from 15.4%. The company ended the quarter with approximately $42 million in cash. However, the net loss widened to $19.8 million from $17 million, whilst operating expenses rose to $28.3 million due to higher employee costs and legal fees. Virginia revenue declined due to reduced wholesale demand. Management highlighted potential benefits from Virginia's adult-use cannabis legislation and the closure of hemp loopholes, focusing on domestic expansion rather than international markets.
[8-K] Jushi Holdings Inc. reports material event. Filing Impact Filing Sentiment Rhea-AI filing summary. Jushi Holdings Inc. reported first quarter 2026 results with revenue of $66.4 million, up from $63.8 million a year earlier, driven by new stores and wholesale growth. Gross profit margin improved to 45.0%, but the company recorded a net loss of $19.8 million. Adjusted EBITDA rose to $11.4 million with a 17.2% margin, and operating cash flow was $8.6 million. Jushi completed a $160.0 million secured term loan refinancing, repaying prior debt and boosting cash to $42.3 million. Management highlighted benefits from federal rescheduling of state-licensed medical marijuana, expected to reduce tax burden over time. Insights. Modest top-line growth, better margins, but losses and leverage remain. Jushi Holdings Inc. posted Q1 2026 revenue of $66.4 million, up 4% year over year, with gross margin rising to 45.0%. Adjusted EBITDA increased to $11.4 million, reflecting improved grower-processor efficiency and greater contribution from Jushi-branded products. The balance sheet shows $42.3 million in cash as of March 31, 2026, but also total gross debt of $222.1 million subject to scheduled repayments. The new $160.0 million term loan due 2029 extends maturities yet locks in a 12.5% coupon, sustaining high interest expense. Federal rescheduling of state-licensed medical marijuana to Schedule III, with medical sales about 60% of 2025 revenue, should ease tax pressure by eliminating Section 280E for those operations. Actual financial benefit will depend on future profitability and any further regulatory changes disclosed in subsequent periods. 8-K event classification. 2 items: 2.02, 9.01 Key figures. Revenue: $66.4 million Gross profit margin: 45.0% Net loss: $19.8 million +5 more Key terms. Adjusted EBITDA, original issue discount, Schedule III, Section 280E, +2 more Earnings snapshot. Revenue: $66.4 million 05/12/2026 - 01:05 PM UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): (Exact name of registrant as specified in its charter) (Address of Principal Executive Offices) (Registrant's telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Filing exhibits & attachments. 5 documents Press releases.
Jushi Holdings Inc reported mixed fourth-quarter 2025 results, with revenue growing 4% year-over-year whilst navigating challenging market conditions. The cannabis company posted gross profit of $28.6 million, representing 41.9% of revenue, up from 38.6% in the prior year. Adjusted EBITDA reached $13.9 million with a 20.4% margin, driven by operational improvements. However, the company reported a net loss of $15.6 million, compared to a $12.5 million loss the previous year. Jushi successfully refinanced its debt, strengthening its balance sheet. The company is positioning for growth in Virginia's anticipated adult-use cannabis market, leveraging existing infrastructure. Full-year gross margins declined slightly to 43.4% from 45.9%, reflecting ongoing pricing pressure across markets. Branded sales constitute mid-60% of revenue in most markets.
Jushi Holdings, a multi-state cannabis operator, has completed a $160 million refinancing of its senior secured and second lien credit facilities through a new term loan with funds managed by FocusGrowth Asset Management and other syndicate members. The term loan was issued at a 4% discount, carries a 12.5% annual interest rate payable monthly, and matures in three years. The non-dilutive financing does not amortise and is secured by company assets. Following the refinancing and debt repayment, Jushi has approximately $35 million in cash and equivalents. CEO James Cacioppo participated in the loan with $28 million, whilst founder Denis Arsenault contributed $21 million. The company will report its fourth quarter 2025 financial results on 31 March 2026.